These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16955456)

  • 21. A rationale for the treatment of hemochromatosis.
    Crosby WH
    Tex Med; 1971 Dec; 67(12):79-80. PubMed ID: 5129501
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemochromatosis.
    Davis WD
    J La State Med Soc; 1974 Jul; 126(7):247-9. PubMed ID: 4603081
    [No Abstract]   [Full Text] [Related]  

  • 23. Leeching as a substitute for phlebotomy.
    Nagler M; Wuillemin WA
    Br J Haematol; 2011 May; 153(4):420. PubMed ID: 21410450
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of hemochromatosis and its complications].
    Brissot P; Bardou-Jacquet E; Ropert M; Loréal O
    Soins; 2007 Jun; (716):40-2. PubMed ID: 17718032
    [No Abstract]   [Full Text] [Related]  

  • 25. G80S-linked ferroportin disease: the first clinical description in a Greek family.
    Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
    Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
    [No Abstract]   [Full Text] [Related]  

  • 26. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
    Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
    Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of hereditary hemochromatosis].
    Saglini V; Lazzaro M; Keller F; Perren A
    Rev Med Suisse; 2007 Sep; 3(123):1952-7. PubMed ID: 17918491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary hemochromatosis.
    Davis NE
    J Insur Med; 2001; 33(3):260-1. PubMed ID: 11558407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of oxidative stress in the skeletal muscle of patients on haemodialysis.
    Crowe AV; McArdle A; McArdle F; Pattwell DM; Bell GM; Kemp GJ; Bone JM; Griffiths RD; Jackson MJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1177-83. PubMed ID: 17213227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate recovery is lower following supine exercise in asymptomatic hereditary hemochromatosis subjects compared with healthy controls.
    Arena R; Shizukuda Y; Bolan CD; Tripodi DJ; Yau YY; Smith KP; Waclawiw MA; Leitman SF; Rosing DR
    J Cardiopulm Rehabil Prev; 2007; 27(3):157-60. PubMed ID: 17558198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juvenile iron overload--advances, but no answers.
    Walker NA; Crawford DH; Subramaniam VN; Wallace DF
    J Pediatr; 2008 Oct; 153(4):588. PubMed ID: 18847628
    [No Abstract]   [Full Text] [Related]  

  • 32. Hereditary hemochromatosis.
    Ayoub W; Martin P; Tran T
    MedGenMed; 2003 May; 5(2):11. PubMed ID: 14603110
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
    Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
    Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver and iron metabolism--a comprehensive hypothesis for the pathogenesis of genetic hemochromatosis.
    Stremmel W; Karner M; Manzhalii E; Gilles W; Herrmann T; Merle U
    Z Gastroenterol; 2007 Jan; 45(1):71-5. PubMed ID: 17236123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress markers in aqueous humor of patients with senile cataracts.
    Sawada H; Fukuchi T; Abe H
    Curr Eye Res; 2009 Jan; 34(1):36-41. PubMed ID: 19172468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults.
    Xu Y; Wang Y; Zheng Q; Li X; Li B; Jin Y; Sun X; Sun G
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):142-9. PubMed ID: 18640141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
    Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of oxidative and antioxidative parameters in etiopathogenesis and prognosis of panic disorder.
    Ersoy MA; Selek S; Celik H; Erel O; Kaya MC; Savas HA; Herken H
    Int J Neurosci; 2008 Jul; 118(7):1025-37. PubMed ID: 18569158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of oxidative stress in schizophrenic and control subjects.
    Young J; McKinney SB; Ross BM; Wahle KW; Boyle SP
    Prostaglandins Leukot Essent Fatty Acids; 2007 Feb; 76(2):73-85. PubMed ID: 17197163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress in hypertension: association with antihypertensive treatment.
    Khanna HD; Sinha MK; Khanna S; Tandon R
    Indian J Physiol Pharmacol; 2008; 52(3):283-7. PubMed ID: 19552060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.